Tibet Weixinkang Medicine Co., Ltd. (603676.SS) SHH

11.63

+0.03(+0.26%)

Updated at September 30 10:38AM

Currency In CNY

Valuation

Market Cap4.3B
Enterprise Value4.09B
P/E Ratio18.47
PEG Ratio1.45
Price/Sales Ratio4
Price/Book Ratio3.29
Enterprise/Revenue3.81
Enterprise/EBITDA15.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.21
Operating Margin0.27

Management Effectiveness

Return On Assets0.14
Return On Equity0.18

Income Statement

Revenue1.3B
Revenue/Share2.96
Gross Profit705.3M
EBITDA329.72M
Net Income246.17M
Diluted EPS0.57

Balance Sheet

Total Cash1.03B
Total Cash/Share2.43
Total Debt1.07M
Total Debt/Equity0
Current Ratio3.84
Book Value Per Share3.53

Price History

52-Week Change28.32
52-Week High14.94
52-Week Low7.9
Moving Average 50 Days12.61
Moving Average 200 Days10.91

Statistics

Average Volume10.15M
Shares Outstanding432.42M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.34
Trailing Annual Dividend Yield2.95
Payout Ratio0.84
Last Split FactorN/A
Last Split DateN/A